Rifaximin therapy and hepatic encephalopathy: Pros and cons

doi:10.4292/wjgpt.v3.i4.62

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3360)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

421

HTML

2939

Sum=3360

Aug 6, 2012 (publication date) through May 21, 2024

Times Cited of This Article

Times Cited (29)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastrointest Pharmacol Ther. Aug 6, 2012; 3(4): 62-67
Published online Aug 6, 2012. doi: 10.4292/wjgpt.v3.i4.62

Rifaximin therapy and hepatic encephalopathy: Pros and cons

Angelo Zullo, Cesare Hassan, Lorenzo Ridola, Roberto Lorenzetti, Salvatore MA Campo, Oliviero Riggio

Angelo Zullo, Cesare Hassan, Roberto Lorenzetti, Salvatore MA Campo, Gastroenterology and Digestive Endoscopy, Nuovo Regina Margherita Hospital, 00153 Rome, Italy

Lorenzo Ridola, Oliviero Riggio, Department of Clinical Medicine, Centre for the Diagnosis and Treatment of Portal Hypertension, “Sapienza” University of Rome, 00185 Rome, Italy

Author contributions: All the authors contributed to this manuscript.

Correspondence to: Dr. Angelo Zullo, MD, Gastroenterology and Digestive Endoscopy, Nuovo Regina Margherita Hospital,Via E. Morosini, 30, 00153 Roma, Italy. zullo66@yahoo.it

Telephone: +39-6-58446533 Fax: +39-6-58446608

Received: July 7, 2011
Revised: June 14, 2012
Accepted: June 20, 2012
Published online: August 6, 2012

Core Tip